<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CEP</journal-id>
<journal-title-group>
<journal-title>Clinical and Experimental Pediatrics</journal-title><abbrev-journal-title>Clin Exp Pediatr</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2713-4148</issn>
<publisher>
<publisher-name>Korean Pediatric Society</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3345/cep.2025.00969</article-id>
<article-id pub-id-type="publisher-id">cep-2025-00969</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
<subj-group subj-group-type="heading">
<subject>General Pediatrics</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>Bridging the gap: autism spectrum disorder in children in the United States and worldwide: a narrative review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0000-2804-1742</contrib-id>
<name><surname>Kadam</surname><given-names>Sandhya J.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="corresp" rid="c1-cep-2025-00969"/>
<xref ref-type="aff" rid="af1-cep-2025-00969"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2358-1528</contrib-id>
<name><surname>Goel</surname><given-names>Malika</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="af2-cep-2025-00969"><sup>2</sup></xref>
</contrib>
<aff id="af1-cep-2025-00969">
<label>1</label>Department of Pediatrics, Family HealthCare Network, Visalia, CA, <country>USA</country></aff>
<aff id="af2-cep-2025-00969">
<label>2</label>Fellow Pediatric Gastroenterology, University of California, San Francisco, CA, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-cep-2025-00969">Corresponding author: Sandhya J. Kadam, MD. Department of Pediatrics, Family HealthCare Network, 4121 W Elowin CT, Visalia, CA, USA Email: <email>hellosandhya7@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<month>11</month>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>10</month>
<year>2025</year></pub-date>
<volume>68</volume>
<issue>11</issue>
<fpage>852</fpage>
<lpage>857</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>04</month>
<year>2025</year></date>
<date date-type="rev-recd">
<day>21</day>
<month>07</month>
<year>2025</year></date>
<date date-type="accepted">
<day>21</day>
<month>07</month>
<year>2025</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000a9; 2025 by The Korean Pediatric Society</copyright-statement>
<copyright-year>2025</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract><p>Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by difficulty with communication and social interactions as well as restricted or repetitive behaviors. Over the last few decades, the prevalence of ASD has increased globally, with major differences in reporting, diagnosis, and interventions between developed and developing countries. The United States (U.S.) has seen a sharp rise in diagnosed ASD cases, with a current prevalence of approximately 1 in 31 children, due to improved awareness, early screening programs, and timely intervention. The U.S. healthcare system supports early intervention services through policies such as the Individuals with Disabilities Education Act and insurance mandates for ASD coverage. However, countries in Latin America, Africa, and Asia face challenges in ASD care, including limited access, stigma, underdiagnosis, and lack of resources. The World Health Organization Caregiver Skills Training, a global initiative, and the involvement of nongovernmental organizations are gradually bridging this gap. An interprofessional approach highlighting cross-cultural research, training providers, screening tools, referral options, policy implementation, and community-based care on a global scale will help reduce disparities in ASD care among countries. Making ASD care a global public health priority could help ensure developmental and mental healthcare equity. This study compares ASD care in the U.S. to that worldwide, highlighting the importance of global collaboration for early detection, service availability, and research.</p></abstract>
<kwd-group>
<kwd>Autism spectrum disorder</kwd>
<kwd>Applied behavior analysis</kwd>
<kwd>Communication social interaction</kwd>
<kwd>Occupational therapy</kwd>
<kwd>Child</kwd>
</kwd-group>
</article-meta>
<notes>
<title>Key message</title>
<boxed-text>
<p>The prevalence of autism is increasing worldwide. The United States has the highest numbers, likely due to the availability of better treatment options. However, global disparities exist, especially in low-resource settings in which stigma, underdiagnosis, and limited services hinder care. A coordinated international approach emphasizing early screening, inclusive policies, and culturally sensitive support systems can bridge this gap and improve the outcomes for children with autism and their families worldwide.</p>
</boxed-text>
</notes></front>
<body>
<p><xref rid="f1-cep-2025-00969" ref-type="fig"/></p>
<p><bold>Graphical abstract.</bold> ASD, autism spectrum disorder.</p>
<sec sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is among the most prevalent neurodevelopmental disorders in children. While its management has advanced significantly in some parts of the world, especially the United States (U.S.), disparities persist globally.</p>
</sec>
<sec>
<title>Children with ASD in U.S.</title>
<p>According to the Centers for Disease Control and Prevention Autism and Developmental Disabilities Monitoring Network report, the prevalence of ASD in the U.S. is currently approximately 1 in 31 children compared to 1 in 150 in 2000 &#x0005b;<xref ref-type="bibr" rid="b1-cep-2025-00969">1</xref>&#x0005d;. This increased prevalence is likely related to enhanced awareness, screening and diagnostic tools, and early intervention facilities. Pediatricians routinely screen children for ASD at 18 and 24 months using ASD screening questionnaires such as the Modified Checklist for Autism in Toddlers, Revised (M-CHAT-R) &#x0005b;<xref ref-type="bibr" rid="b1-cep-2025-00969">1</xref>&#x0005d;.</p>
<p>The M-CHAT-R and M-CHAT-R with Follow-up (M-CHAT-RF) consist of 20 questions each. In the M-CHAT-R, responses are recorded as yes or no, whereas in the M-CHAT-RF, they are marked as Pass or Fail. For children who receive a normal M-CHAT score of zero, the expected pattern of responses is as follows: questions 2, 5, and 12 should be answered &quot;no,&quot; and all remaining questions should be answered &quot;yes.&quot; Any deviation from this response pattern is considered abnormal, with each incorrect answer contributing 1 point to the total M-CHAT score. M-CHAT grading indicates patients at low, medium, or high risk &#x0005b;<xref ref-type="bibr" rid="b2-cep-2025-00969">2</xref>&#x0005d;.</p>
<p>A score of 0&#x02013;2 on the M-CHAT-R indicates low risk, for which no further action is necessary. A score of 3&#x02013;7 suggests moderate risk; in such cases, the M-CHAT-RF should be administered. Only the items marked as at risk on the initial M-CHAT-R are then reviewed during follow-up. If 2 or more of these items remain at risk after follow-up, the child should be referred immediately for further evaluation. Children who score 8&#x02013;20 are considered at high risk and should be referred immediately for a comprehensive diagnostic assessment and early intervention services. Additionally, if there are concerns about possible signs of ASD from the pediatrician or parent, a referral should be made regardless of the child&#x02019;s M-CHAT score &#x0005b;<xref ref-type="bibr" rid="b2-cep-2025-00969">2</xref>&#x0005d;.</p>
<p>Children are referred to specialists for speech, vision, hearing, and ASD evaluations. Children at medium risk are re-evaluated using the M-CHAT-RF, and further management is decided based on the re-evaluation scores. All patients with speech delays begin speech therapy, and based on the confirmation of ASD, start receiving specific ASD services. Insurance coverage mandates support therapies such as applied behavior analysis (ABA) and occupational and speech therapy. However, insurance benefits for ASD services vary significantly across states and are influenced by insurance plan coverages. The National Institutes of Health provides research funding, while organizations such as Autism Speaks advocate for advanced services and support networks. These systems help with the inclusion of, acceptance of, and early intervention for children with ASD &#x0005b;<xref ref-type="bibr" rid="b3-cep-2025-00969">3</xref>&#x0005d;.</p>
<p>Public school systems are mandated to support children with ASD under the Individuals with Disabilities Education Act (IDEA) &#x0005b;<xref ref-type="bibr" rid="b1-cep-2025-00969">1</xref>&#x0005d;. According to the IDEA, children under 3 years of age at risk of developmental delays are eligible for early intervention services. Treatment of specific symptoms, such as speech therapy for language delays, does not require the receipt of a formal ASD diagnosis. Children with ASD and other disabilities are eligible for services through the local education system starting at 3 years of age by receiving an Individualized Education Program or 504 plan and starting services before formally starting school. Parents can also ask for an evaluation by contacting their local public school system, even if the child is not yet old enough for kindergarten or not enrolled in a public school through a program called &quot;Child Find.&quot; &#x0005b;<xref ref-type="bibr" rid="b4-cep-2025-00969">4</xref>&#x0005d;</p>
<p>Under the IDEA, children with ASD receive a range of free services in public schools, including speech and occupational therapies to support fine motor skills and sensory processing. They also receive physical therapy to address motor development and movement difficulties and behavioral interventions to address challenging behaviors and promote positive behaviors. The program also provides social skills training and assistive technology, such as tablets, to enhance the child&#x00027;s learning and communication. ABA develops specific skills in a systematic manner to improve the overall quality of life of children with ASD. The IDEA mandates that children with disabilities, including those with ASD, be educated alongside their nondisabled peers whenever possible to foster inclusion and social interactions &#x0005b;<xref ref-type="bibr" rid="b4-cep-2025-00969">4</xref>&#x0005d;.</p>
</sec>
<sec>
<title>Children with ASD worldwide</title>
<p>Asian, African, and Latin American countries face major obstacles to ASD care. Their exact prevalence data are not available because of underdiagnosis related to stigma, cultural factors, limited screening tools, and a lack of management services. According to a study in 2022 by Zeidan et al. &#x0005b;<xref ref-type="bibr" rid="b5-cep-2025-00969">5</xref>&#x0005d;, the global ASD median prevalence within and across regions is 100/10,000 (range, 1.09/10,000&#x02013;436.0/ 10,000). In India, studies report a wide ASD prevalence range (0.09%&#x02013;1%) depending on the population and diagnostic criteria used &#x0005b;<xref ref-type="bibr" rid="b5-cep-2025-00969">5</xref>&#x0005d;.</p>
<p>In Sub-Saharan Africa, ASD remains highly stigmatized and is often misunderstood as a spiritual or behavioral issue rather than a medical condition. Limited healthcare infrastructure, scarce resources, and lacking public policy create further barriers to care &#x0005b;<xref ref-type="bibr" rid="b6-cep-2025-00969">6</xref>&#x0005d;. Similarly, in parts of Southeast Asia and the Middle East, the diagnosis often occurs late; moreover, only few educational or therapeutic services are available. Language, cultural beliefs, and socioeconomic constraints also affect its perception and management. In low-resource areas, social stigma, shame, and cultural norms dominate, leading families to conceal their children&#x02019;s conditions and seek alternatives &#x0005b;<xref ref-type="bibr" rid="b6-cep-2025-00969">6</xref>&#x0005d;.</p>
<p>Despite the presence of disparities between developing and developed countries, the global prevalence of ASD is increasing, likely due to the efforts of individual countries, the World Health Organization (WHO), and the involvement of nongovernmental organizations. In India, along with the M-CHAT, the Trivandrum Autism Behavioral Checklist and Social Communication Questionnaire (SCQ) are used to screen for and evaluate ASD &#x0005b;<xref ref-type="bibr" rid="b7-cep-2025-00969">7</xref>&#x0005d;.</p>
<p>In 2023, Chakrabarti &#x0005b;<xref ref-type="bibr" rid="b8-cep-2025-00969">8</xref>&#x0005d; described various factors, such as population size, diet, environmental, genetic, social, and economic, and the inclusion of children with ASD in mainstream schools in India, as components of effective ASD management as well as the need to create a national ASD program.</p>
<p>In South Korea, along with the M-CHAT and SCQ, the Social Responsiveness Scale and Behavior Development Screening for Toddlers are also used. Developmental screenings are performed 8 times in children aged 2 weeks to 6 years. The Korean Developmental Screening Test for Infants and Children includes 6 domains, and children older than 1 year of age are screened for additional items specific to ASD &#x0005b;<xref ref-type="bibr" rid="b9-cep-2025-00969">9</xref>&#x0005d;. South Korea has a national program supporting patients with ASD. Children with ASD, speech delays, or intellectual disabilities can be registered with the Korea National Disability Registration System to obtain social welfare benefits &#x0005b;<xref ref-type="bibr" rid="b10-cep-2025-00969">10</xref>&#x0005d;. South Korea is making progress in helping children with ASD. However, some target areas require more investment and development, as Kim et al. &#x0005b;<xref ref-type="bibr" rid="b11-cep-2025-00969">11</xref>&#x0005d; studied in 2019 by comparing ASD services in Massachusetts, U.S., and Seoul, Korea.</p>
<p>According to the National Autistic Society, approximately 1% of the population in the United Kingdom (U.K.) has ASD. The U.K.&#x00027;s National Strategy for People 2021&#x02013;2026 highlights key roles such as ASD acceptance and understanding, improved educational opportunities, healthcare equality, and helping young adults become more independent and transition smoothly to adulthood. This policy covers children, young people, and adults with ASD &#x0005b;<xref ref-type="bibr" rid="b12-cep-2025-00969">12</xref>&#x0005d;.</p>
<p>Based on data from the Department of Social Services, National Disability Insurance Agency, increasing Australians have ASD, with higher risk of premature deaths, unemployment, and academic difficulties, Australia has developed a national ASD strategy that includes 22 commitments highlighting services provided to, diagnostic strategies for, and health and social economic help for patients with ASD &#x0005b;<xref ref-type="bibr" rid="b13-cep-2025-00969">13</xref>&#x0005d;.</p>
<p>In 2023, a study conducted in New Zealand described the current policy and plans to support patients with ASD, which highlighted its national ASD strategy to enhance educational, social, economic, and inclusion opportunities and provide future research directions &#x0005b;<xref ref-type="bibr" rid="b14-cep-2025-00969">14</xref>&#x0005d;.</p>
<p>The prevalence of ASD has been steadily increasing over the last 3 decades in European countries, with estimates of 1%&#x02013;2% among schoolchildren. In 2023, Mendez et al. &#x0005b;<xref ref-type="bibr" rid="b15-cep-2025-00969">15</xref>&#x0005d; surveyed 3 European countries to examine the challenges to receiving ASD care. The study found some barriers, such as long waiting times to obtain a diagnosis, limited access to interventions, a lack of sufficient support for families, and unavailability of adequate information about ASD. These findings highlight the need to strengthen European policy to improve the quality of life of children with ASD and their families.</p>
<p>In 2023, Fong et al. &#x0005b;<xref ref-type="bibr" rid="b16-cep-2025-00969">16</xref>&#x0005d; studied the needs of native and newcomer families of patients with ASD in Canada. In that study, native families preferred to receive services in rural and remote areas while preserving their cultural norms. Newcomer families prioritized quality services, including therapy and peer support. Both groups reported longer wait times similar to those of the general population. The findings emphasize the need for service structure and function to accommodate the needs of patients with ASD in underserved communities.</p>
</sec>
<sec>
<title>Efforts to minimize disparities</title>
<p>Despite these challenges, several global initiatives have been developed. The WHO Caregiver Skills Training program empowers parents of children with developmental disorders, including ASD, via community-based training sessions in more than 30 countries. Nongovernmental organizations and local advocacy groups are working to improve awareness and provide support, while academic partnerships are helping to develop culturally appropriate screening tools &#x0005b;<xref ref-type="bibr" rid="b17-cep-2025-00969">17</xref>&#x0005d;.</p>
<p>After receiving feedback from widespread field testing in various regions and discussions with international experts, family advocates, caregivers, and service providers, the WHO has created 5 different packages of the Caregiver Skills Training program for parents of children with disabilities, including ASD, to increase their parenting skills and confidence. The program is delivered by nurses, community-based workers, or caregivers and includes health education and social services for children and their families. The 5 Caregiver Skills Training program documents include introduction, adaptation, facilitator, participant, and home sections &#x0005b;<xref ref-type="bibr" rid="b18-cep-2025-00969">18</xref>&#x0005d;. The program includes 9 group sessions and 3 home visits to teach caregivers how to include a child&#x00027;s daily activities to promote social interaction, communication, and learning. The sessions target participation, development, engagement, daily living skills, the management of challenging behaviors in children with ASD, and the development of coping strategies for caregivers &#x0005b;<xref ref-type="bibr" rid="b18-cep-2025-00969">18</xref>&#x0005d;.</p>
<p>Autism Europe, an international organization, is improving the quality of life of people with ASD and their families in 40 European countries via 90 ASD organizations. Autism Europe is increasing public awareness and advocating for the rights of patients with ASD &#x0005b;<xref ref-type="bibr" rid="b19-cep-2025-00969">19</xref>&#x0005d;.</p>
<p>ASD care and services differ significantly between developing and developed countries within specific regions. However, each country is making progress at both regional and national levels. For example, developed nations such as the U.K. have introduced initiatives such as the National Autism Strategy 2021&#x02013;2026 &#x0005b;<xref ref-type="bibr" rid="b12-cep-2025-00969">12</xref>&#x0005d;. There are several national and international resources for ASD empowerment, including ANCA and Autism Society in Canada, Irish Society for Autism in Ireland, Autism All Stars UK, and The National Autistic Society in UK, Autism Association of Western Australia, and Autism Aspergers Advocacy in Australia. There are multicultural ASD organizations, such as Autismo Diario and online ASD communities, such as MyAutismTeam and WrongPlanet.net, that help patients with ASD &#x0005b;<xref ref-type="bibr" rid="b20-cep-2025-00969">20</xref>&#x0005d;. (<xref rid="t1-cep-2025-00969" ref-type="table">Tables 1</xref>, <xref rid="t2-cep-2025-00969" ref-type="table">2</xref>)</p>
</sec>
<sec>
<title>Future directions</title>
<p>ASD care must be prioritized within national health and education strategies; moreover, there is a need for extensive efforts to close this gap. Training healthcare professionals through continuous medical education programs and the integration of M-CHAT screening at the 18- and 24-month wellness visits for every child can aid the early diagnosis. Moreover, future research to understand the different presentations of ASD across countries affected by cultural factors could aid the development of tailored interventions. Thus, a global response must extend beyond diagnostics and include support and social inclusion for families. Equity in ASD care requires policy, community, and healthcare system alignments. Learning from the U.S. experience of adapting successful models to the local context and international collaboration can facilitate the sharing of ASD knowledge, resources, and management options among healthcare professionals. ASD has no geographical limitations, but its available resources are limited; therefore, addressing this gap is a moral responsibility &#x0005b;<xref ref-type="bibr" rid="b1-cep-2025-00969">1</xref>-<xref ref-type="bibr" rid="b20-cep-2025-00969">20</xref>&#x0005d;.</p>
<p>The early diagnosis of ASD can help children receive early intervention services to facilitate patient acquisition of adaptive skills, improve long-term outcomes, and improve the overall quality of life of patients and families. In 2023, Okoye et al. &#x0005b;<xref ref-type="bibr" rid="b21-cep-2025-00969">21</xref>&#x0005d; reviewed the benefits of the early diagnosis of ASD as well as the possible risks, including overdiagnosis or misdiagnosis. An early ASD diagnosis can cause social stigma that affects the child&#x00027;s interaction with their environment. Children and caregivers face the complicated process of an ASD evaluation performed by different specialists to arrive at a challenging diagnosis. That review emphasized the importance of using a logical approach, using correct tools, and including artificial intelligence to arrive at an accurate, confirmatory, and timely diagnosis of ASD.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict"><p><bold>Conflicts of interest</bold></p><p>No potential conflict of interest relevant to this article was reported.</p></fn>
<fn fn-type="financial-disclosure"><p><bold>Funding</bold></p><p>This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
<fn fn-type="participating-researchers"><p><bold>Author contribution</bold></p><p>Conceptualization: SJK, MG; Data curation: SJK, MG; Formal analysis: SJK, MG; Project administration: SJK, MG; Visualization: SJK, MG; Writing - original draft: SJK, MG; Writing - review &amp; editing: SJK, MG</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-cep-2025-00969">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shaw</surname><given-names>KA</given-names></name>
<name><surname>Williams</surname><given-names>S</given-names></name>
<name><surname>Patrick</surname><given-names>ME</given-names></name>
<name><surname>Valencia-Prado</surname><given-names>M</given-names></name>
<name><surname>Durkin</surname><given-names>MS</given-names></name>
<name><surname>Howerton</surname><given-names>EM</given-names></name>
<etal/>
</person-group>
<article-title>Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years &#x02014; autism and developmental disabilities monitoring network, 16 sites, United States, 2022</article-title>
<source>MMWR Surveill Summ</source>
<year>2025</year>
<volume>74</volume>
<fpage>1</fpage>
<lpage>22</lpage>
</element-citation></ref>
<ref id="b2-cep-2025-00969">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Robins</surname><given-names>DL</given-names></name>
<name><surname>Casagrande</surname><given-names>K</given-names></name>
<name><surname>Barton</surname><given-names>M</given-names></name>
<name><surname>Chen</surname><given-names>CM</given-names></name>
<name><surname>Dumont-Mathieu</surname><given-names>T</given-names></name>
<name><surname>Fein</surname><given-names>D</given-names></name>
</person-group>
<article-title>Validation of the modified checklist for Autism in toddlers, revised with follow-up (M-CHAT-R/F)</article-title>
<source>Pediatrics</source>
<year>2014</year>
<volume>133</volume>
<fpage>37</fpage>
<lpage>45</lpage>
</element-citation></ref>
<ref id="b3-cep-2025-00969">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hodges</surname><given-names>H</given-names></name>
<name><surname>Fealko</surname><given-names>C</given-names></name>
<name><surname>Soares</surname><given-names>N</given-names></name>
</person-group>
<article-title>Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation</article-title>
<source>Transl Pediatr</source>
<year>2020</year>
<volume>9(Suppl 1)</volume>
<fpage>S55</fpage>
<lpage>65</lpage>
</element-citation></ref>
<ref id="b4-cep-2025-00969">
<label>4</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Centers for Disease Control and Prevention (CDC)</collab>
</person-group>
<article-title>Accessing services for autism spectrum disorder [Internet]</article-title>
<publisher-loc>Atlanta (GA)</publisher-loc>
<publisher-name>Centers for Disease Control and Prevention</publisher-name>
<year>2025</year>
<comment>[cited 2025 Mar 3]. Available from: <ext-link xlink:href="https://www.cdc.gov/autism/treatment/accessing-services.html" ext-link-type="uri">https://www.cdc.gov/autism/treatment/accessing-services.html</ext-link></comment>
</element-citation></ref>
<ref id="b5-cep-2025-00969">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Zeidan</surname><given-names>J</given-names></name>
<name><surname>Fombonne</surname><given-names>E</given-names></name>
<name><surname>Scorah</surname><given-names>J</given-names></name>
<name><surname>Ibrahim</surname><given-names>A</given-names></name>
<name><surname>Durkin</surname><given-names>MS</given-names></name>
<name><surname>Saxena</surname><given-names>S</given-names></name>
<etal/>
</person-group>
<article-title>Global prevalence of autism: a systematic review update</article-title>
<source>Autism Res</source>
<year>2022</year>
<volume>15</volume>
<fpage>778</fpage>
<lpage>90</lpage>
</element-citation></ref>
<ref id="b6-cep-2025-00969">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Talantseva</surname><given-names>OI</given-names></name>
<name><surname>Romanova</surname><given-names>RS</given-names></name>
<name><surname>Shurdova</surname><given-names>EM</given-names></name>
<name><surname>Dolgorukova</surname><given-names>TA</given-names></name>
<name><surname>Sologub</surname><given-names>PS</given-names></name>
<name><surname>Titova</surname><given-names>OS</given-names></name>
<etal/>
</person-group>
<article-title>The global prevalence of autism spectrum disorder: a three-level meta-analysis</article-title>
<source>Front Psychiatry</source>
<year>2023</year>
<volume>14</volume>
<fpage>1071181</fpage>
</element-citation></ref>
<ref id="b7-cep-2025-00969">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Uke</surname><given-names>P</given-names></name>
<name><surname>Gaikwad</surname><given-names>S</given-names></name>
<name><surname>Vagha</surname><given-names>K</given-names></name>
<name><surname>Wandile</surname><given-names>S</given-names></name>
</person-group>
<article-title>Unraveling the spectrum: a comprehensive review of autism spectrum disorder in India</article-title>
<source>Cureus</source>
<year>2024</year>
<volume>16</volume>
<elocation-id>e62753</elocation-id>
</element-citation></ref>
<ref id="b8-cep-2025-00969">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chakrabarti</surname><given-names>B</given-names></name>
</person-group>
<article-title>Autism in India: time for a national programme</article-title>
<source>Indian J Med Res</source>
<year>2023</year>
<volume>157</volume>
<fpage>227</fpage>
<lpage>9</lpage>
</element-citation></ref>
<ref id="b9-cep-2025-00969">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JI</given-names></name>
<name><surname>Yoo</surname><given-names>HJ</given-names></name>
</person-group>
<article-title>Diagnosis and assessment of autism spectrum disorder in South Korea</article-title>
<source>J Korean Acad Child Adolesc Psychiatry</source>
<year>2024</year>
<volume>35</volume>
<fpage>15</fpage>
<lpage>21</lpage>
</element-citation></ref>
<ref id="b10-cep-2025-00969">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>M</given-names></name>
<name><surname>Jung</surname><given-names>W</given-names></name>
<name><surname>Kim</surname><given-names>SY</given-names></name>
<name><surname>Park</surname><given-names>JH</given-names></name>
<name><surname>Shin</surname><given-names>DW</given-names></name>
</person-group>
<article-title>The Korea National Disability Registration System</article-title>
<source>Epidemiol Health</source>
<year>2023</year>
<volume>45</volume>
<elocation-id>e2023053</elocation-id>
</element-citation></ref>
<ref id="b11-cep-2025-00969">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JW</given-names></name>
<name><surname>Kim</surname><given-names>HW</given-names></name>
<name><surname>Moon</surname><given-names>DS</given-names></name>
<name><surname>Lim</surname><given-names>YS</given-names></name>
<name><surname>McDougle</surname><given-names>CJ</given-names></name>
<name><surname>Howe</surname><given-names>YJ</given-names></name>
</person-group>
<article-title>Comparison of services for autism spectrum disorder in Massachusetts with those in Seoul</article-title>
<source>J Korean Med Sci</source>
<year>2019</year>
<volume>34</volume>
<elocation-id>e288</elocation-id>
</element-citation></ref>
<ref id="b12-cep-2025-00969">
<label>12</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>GOV.UK</collab>
</person-group>
<article-title>The national strategy for autistic children, young people and adults: 2021 to 2026 [Internet]</article-title>
<source>GOV.UK</source>
<comment>2021 to 2026 [Internet]. Available from: <ext-link xlink:href="https://assets.publishing.service.gov.uk/media/60f72556e90e0764c6eb39f5/thenational-strategy-for-autistic-children-young-people-andadults-2021-to-2026.pdf" ext-link-type="uri">https://assets.publishing.service.gov.uk/media/60f72556e90e0764c6eb39f5/thenational-strategy-for-autistic-children-young-people-andadults-2021-to-2026.pdf</ext-link></comment>
</element-citation></ref>
<ref id="b13-cep-2025-00969">
<label>13</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>E</given-names></name>
<name><surname>Campanella</surname><given-names>N</given-names></name>
</person-group>
<article-title>Australia now has a national autism strategy. Here's what's in it and why it's needed [Internet]</article-title>
<publisher-loc>Sydney (Australia)</publisher-loc>
<publisher-name>Australian Broadcasting Corporation</publisher-name>
<year>2025</year>
<comment>[cited 2025 Mar 8]. Available from: <ext-link xlink:href="https://www.abc.net.au/news/2025-01-13/national-autism-strategy-released-employment-inclusion-health/104792744" ext-link-type="uri">https://www.abc.net.au/news/2025-01-13/national-autism-strategy-released-employment-inclusion-health/104792744</ext-link></comment>
</element-citation></ref>
<ref id="b14-cep-2025-00969">
<label>14</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name><surname>van der Meer</surname><given-names>L</given-names></name>
<name><surname>Moriah</surname><given-names>C</given-names></name>
<name><surname>Patrick</surname><given-names>L</given-names></name>
<name><surname>Waddington</surname><given-names>W</given-names></name>
</person-group>
<article-title>How do we get autism support right in Aotearoa New Zealand? Final Report</article-title>
<publisher-loc>St Lucia</publisher-loc>
<publisher-name>Autism CRC</publisher-name>
<year>2024</year>
<comment>[cited 2025 Mar 26]. Available from: <ext-link xlink:href="https://www.autismcrc.com.au/news/latest-news/how-do-we-get-autism-support-right-inaotearoa-new-zealand" ext-link-type="uri">https://www.autismcrc.com.au/news/latest-news/how-do-we-get-autism-support-right-inaotearoa-new-zealand</ext-link></comment>
</element-citation></ref>
<ref id="b15-cep-2025-00969">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Mendez</surname><given-names>MA</given-names></name>
<name><surname>Oakley</surname><given-names>B</given-names></name>
<name><surname>Canitano</surname><given-names>R</given-names></name>
<name><surname>San Jos&#x000e9;-C&#x000e1;ceres</surname><given-names>A</given-names></name>
<name><surname>Tinelli</surname><given-names>M</given-names></name>
<name><surname>Knapp</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Autism care pathway in Europe</article-title>
<source>Eur Psychiatry</source>
<year>2023</year>
<volume>66</volume>
<elocation-id>e81</elocation-id>
</element-citation></ref>
<ref id="b16-cep-2025-00969">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fong</surname><given-names>VC</given-names></name>
<name><surname>McLaughlin</surname><given-names>J</given-names></name>
<name><surname>Schneider</surname><given-names>M</given-names></name>
<name><surname>Bruno</surname><given-names>G</given-names></name>
</person-group>
<article-title>Comparing the autism service needs and priorities of Indigenous and newcomer families in Canada: qualitative insights</article-title>
<source>Res Autism Spectr Disord</source>
<year>2024</year>
<volume>111</volume>
<fpage>102314</fpage>
</element-citation></ref>
<ref id="b17-cep-2025-00969">
<label>17</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<article-title>WHO caregiver skills training for families of children with developmental delays or disabilities. Training for caregivers of children with developmental disabilities, including autism [Internet]</article-title>
<publisher-loc>Geneva (Switzerland)</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
<year>2020</year>
<comment>[cited 2025 Mar 21]. Available from: <ext-link xlink:href="https://www.who.int/teams/mental-health-and-substance-use/treatment-care/whocaregivers-skills-training-for-families-of-children-withdevelopmental-delays-and-disorders" ext-link-type="uri">https://www.who.int/teams/mental-health-and-substance-use/treatment-care/whocaregivers-skills-training-for-families-of-children-withdevelopmental-delays-and-disorders</ext-link></comment>
</element-citation></ref>
<ref id="b18-cep-2025-00969">
<label>18</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<article-title>Caregiver skills training for families of children with developmental delays or disabilities [Internet]</article-title>
<publisher-loc>Geneva (Switzerland)</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
<year>2022</year>
<comment>[cited 2025 Apr 1]. Available from: <ext-link xlink:href="https://www.who.int/teams/mental-health-and-substance-use/treatment-care/who-caregivers-skills-training-for-families-of-children-with-developmental-delays-and-disorders" ext-link-type="uri">https://www.who.int/teams/mental-health-and-substance-use/treatment-care/who-caregivers-skills-training-for-families-of-children-with-developmental-delays-and-disorders</ext-link></comment>
</element-citation></ref>
<ref id="b19-cep-2025-00969">
<label>19</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>Autism Europe</collab>
</person-group>
<article-title>Who we are [Internet]</article-title>
<comment>Brussels (Belgium): Autism Europe; [cited 2025 Mar 18]. <ext-link xlink:href="https://www.autismeurope.org/who-we-are/" ext-link-type="uri">https://www.autismeurope.org/who-we-are/</ext-link></comment>
</element-citation></ref>
<ref id="b20-cep-2025-00969">
<label>20</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<collab>National and International Resources</collab>
</person-group>
<article-title>Autism empowerment [Internet]</article-title>
<publisher-loc>Vancouver (WA)</publisher-loc>
<publisher-name>National and International Resources</publisher-name>
<year>2025</year>
<comment>[cited 2025 Apr 6]. Available from: <ext-link xlink:href="https://www.autismempowerment.org/resource-center/nationaland-international-resources/" ext-link-type="uri">https://www.autismempowerment.org/resource-center/nationaland-international-resources/</ext-link></comment>
</element-citation></ref>
<ref id="b21-cep-2025-00969">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Okoye</surname><given-names>C</given-names></name>
<name><surname>Obialo-Ibeawuchi</surname><given-names>CM</given-names></name>
<name><surname>Obajeun</surname><given-names>OA</given-names></name>
<name><surname>Sarwar</surname><given-names>S</given-names></name>
<name><surname>Tawfik</surname><given-names>C</given-names></name>
<name><surname>Waleed</surname><given-names>MS</given-names></name>
<etal/>
</person-group>
<article-title>Early diagnosis of autism spectrum disorder: a review and analysis of the risks and benefits</article-title>
<source>Cureus</source>
<year>2023</year>
<volume>15</volume>
<elocation-id>e43226</elocation-id>
</element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figure and Table</title>
<fig id="f1-cep-2025-00969" position="float">
<graphic xlink:href="cep-2025-00969f1.tif"/></fig>

<table-wrap id="t1-cep-2025-00969" position="float">
<label>Table 1.</label>
<caption><p>Factors related to autism spectrum disorder, United States (U.S.) versus worldwide [<xref ref-type="bibr" rid="b1-cep-2025-00969">1</xref>-<xref ref-type="bibr" rid="b21-cep-2025-00969">21</xref>]</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Factors</th>
<th align="center" valign="middle">Autism spectrum disorder in U.S.</th>
<th align="center" valign="middle">Autism spectrum disorder in the rest of the world</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Prevalence</td>
<td valign="top" align="center">1:31</td>
<td valign="top" align="center">1:100</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="4">Social factors affecting ASD management</td>
<td valign="top" align="left" rowspan="2">Improved awareness among families. Families themselves seek the advice</td>
<td valign="top" align="left">Limited awareness</td>
</tr>
<tr>
<td valign="top" align="left">Language barrier</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Available family support services</td>
<td valign="top" align="left">Social stigma, pressure, and cultural factors. Families try to hide the diagnosis</td>
</tr>
<tr>
<td valign="top" align="left">Lack of family support</td>
</tr>
<tr>
<td valign="top" align="left">Health professionals' related factors</td>
<td valign="top" align="left">Trained health care professionals</td>
<td valign="top" align="left">Shortage of healthcare professionals</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="9">Available resources</td>
<td valign="top" align="left">Availability of screening tools</td>
<td valign="top" align="left">Limited infrastructure</td>
</tr>
<tr>
<td valign="top" align="left">Availability of early intervention</td>
<td valign="top" align="left">Lack of resources</td>
</tr>
<tr>
<td valign="top" align="left">I nsurance coverage</td>
<td valign="top" align="left">Socioeconomic constraints</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">Easily accessible applied behavior therapy, occupational therapy, and speech therapy options</td>
<td valign="top" align="left">Inaccessibility to educational and therapeutic services</td>
</tr>
<tr>
<td valign="top" align="left">World Health Organization&#x02019;s</td>
</tr>
<tr>
<td valign="top" align="left">National Institutes of Health research funding</td>
<td valign="top" align="left">Caregiver Skills Training program</td>
</tr>
<tr>
<td valign="top" align="left">Advocacy from other organizations</td>
<td valign="top" align="left">Nongovernmental organizations involvement</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="2">ASD coverage under the Individuals with Disabilities Education Act</td>
<td valign="top" align="left">Absence of public policy in the developing countries, while some of the developed countries in the region have new national programs</td>
</tr>
<tr>
<td valign="top" align="left">Efforts at national, regional and international levels</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>ASD, autism spectrum disorder.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t2-cep-2025-00969" position="float">
<label>Table 2.</label>
<caption><p>Summary of key published papers related to ASD [<xref ref-type="bibr" rid="b3-cep-2025-00969">3</xref>,<xref ref-type="bibr" rid="b5-cep-2025-00969">5</xref>,<xref ref-type="bibr" rid="b6-cep-2025-00969">6</xref>-<xref ref-type="bibr" rid="b11-cep-2025-00969">11</xref>,<xref ref-type="bibr" rid="b14-cep-2025-00969">14</xref>-<xref ref-type="bibr" rid="b16-cep-2025-00969">16</xref>,<xref ref-type="bibr" rid="b21-cep-2025-00969">21</xref>]</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Title</th>
<th align="center" valign="middle">Year of publication</th>
<th align="center" valign="middle">Authors</th>
<th align="center" valign="middle">Key findings</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation</td>
<td valign="top" align="center">2020</td>
<td valign="top" align="left">Hodges et al. [<xref ref-type="bibr" rid="b3-cep-2025-00969">3</xref>]</td>
<td valign="top" align="left">The clinical evaluation of ASD begins with screening, follows referral for confirmation of diagnosis, and guides screening for comorbid conditions.</td>
</tr>
<tr>
<td valign="top" align="left">Global prevalence of autism: A systematic review update</td>
<td valign="top" align="center">2022</td>
<td valign="top" align="left">Zeidan et al. [<xref ref-type="bibr" rid="b5-cep-2025-00969">5</xref>]</td>
<td valign="top" align="left">The prevalence of autism has increased over time and varies across sociodemographic groups</td>
</tr>
<tr>
<td valign="top" align="left">The global prevalence of autism spectrum disorder: A three-level meta-analysis</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">Talantseva et al. [<xref ref-type="bibr" rid="b6-cep-2025-00969">6</xref>]</td>
<td valign="top" align="left">There was an increase in autism prevalence estimates over time.</td>
</tr>
<tr>
<td valign="top" align="left">Unraveling the Spectrum: A Comprehensive Review of Autism Spectrum Disorder in India</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="left">Uke et al. [<xref ref-type="bibr" rid="b7-cep-2025-00969">7</xref>]</td>
<td valign="top" align="left">Timely interventions and a multidisciplinary approach are necessary for improving the lives of individuals with ASD and for dealing with the rising prevalence of ASD globally.</td>
</tr>
<tr>
<td valign="top" align="left">Autism in India: Time for a national programme</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">Chakrabarti [<xref ref-type="bibr" rid="b8-cep-2025-00969">8</xref>]</td>
<td valign="top" align="left">The article highlights the need for a coordinated national program in India.</td>
</tr>
<tr>
<td valign="top" align="left">Diagnosis and Assessment of Autism Spectrum Disorder in South Korea</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="left">Kim and Yoo [<xref ref-type="bibr" rid="b9-cep-2025-00969">9</xref>]</td>
<td valign="top" align="left">In South Korea, developmental screening is done 8 times in children from the age of 2 wk to 6 yr. The test includes 6 domains, and child&#x000AD; ren more than 1 yr of age are screened with additional items specific to ASD</td>
</tr>
<tr>
<td valign="top" align="left">The Korea National Disability Registration System</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">Kim et al. [<xref ref-type="bibr" rid="b10-cep-2025-00969">10</xref>]</td>
<td valign="top" align="left">The Korea National Disability Registration System is a significant data resource for research on the epidemiology of disabilities.</td>
</tr>
<tr>
<td valign="top" align="left">Comparison of Services for Autism Spectrum Disorder in Massachusetts with Those in Seoul</td>
<td valign="top" align="center">2019</td>
<td valign="top" align="left">Kim et al. [<xref ref-type="bibr" rid="b11-cep-2025-00969">11</xref>]</td>
<td valign="top" align="left">The limited availability of services and interventions for individuals with ASD and their families in Seoul, compared to Massachusetts, highlights key areas that require additional investment and develop&#x000AD; ment.</td>
</tr>
<tr>
<td valign="top" align="left">How do we get autism support right in Aotearoa New Zealand? Final Report</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">van der Meer et al. [<xref ref-type="bibr" rid="b14-cep-2025-00969">14</xref>]</td>
<td valign="top" align="left">Aotearoa New Zealand is undergoing changes in how autism support is provided, making it a crucial time to explore community pers&#x000AD; pectives on future approaches that can best promote inclusion and support for autistic individuals.</td>
</tr>
<tr>
<td valign="top" align="left">Autism care pathway in Europe</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">Mendez et al. [<xref ref-type="bibr" rid="b15-cep-2025-00969">15</xref>]</td>
<td valign="top" align="left">The article found the variability and gaps in the care pathway for autism with co-occurring epilepsy, highlighting the substantial efforts required by caregivers and underscoring the need for policy across Europe to enhance the quality of life for children with ASD.</td>
</tr>
<tr>
<td valign="top" align="left">Comparing the autism service needs and priorities of Indigenous and newcomer families in Canada: Qualitative insights</td>
<td valign="top" align="center">2024</td>
<td valign="top" align="left">Fong et al. [<xref ref-type="bibr" rid="b16-cep-2025-00969">16</xref>]</td>
<td valign="top" align="left">This article highlights differences and similarities between Indigenous and newcomer families in Canada. It explores how these insights can inform the development and provision of appropriate and impactful services and supports for individuals with ASD.</td>
</tr>
<tr>
<td valign="top" align="left">Early Diagnosis of Autism Spectrum Disorder: A Review and Analysis of the Risks and Benefits</td>
<td valign="top" align="center">2023</td>
<td valign="top" align="left">Okoye et al. [<xref ref-type="bibr" rid="b21-cep-2025-00969">21</xref>]</td>
<td valign="top" align="left">This review emphasizes the need for a balanced approach to early autism diagnosis, recognizing its benefits for timely intervention and improved outcomes, while underscoring the importance of accurate diagnostics, family support, societal awareness, and future directions such as biomarkers and AI-based diagnostic tools.</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>ASD, autism spectrum disorder; AI, artificial intelligence.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>